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Background: The residual SYNTAX score (RSS) can be used to measure the residual stenosis severity and 
complexity. The prognostic role of RSS in CCS patients is still unknown. We purposed to investigate the impact 
of RSS on the clinical outcomes following PCI in CCS patients.
Methods: A prospective cohort study was performed. Based on the residual SYNTAX score, patients were divided 
into three groups: RSS 0, RSS 0 to 9.5, and RSS >9.5. The primary outcome was patient-oriented composite 
endpoint (POCE), including repeat revascularization, myocardial infarction, and all-cause mortality.
Results: After 1-year follow-up period, patients in RSS >9.5 group revealed the greater POCE (4.3% vs. 6.4% vs. 
23.9%; p = 0.016) than others. The repeat revascularization rate also was greater in the RSS >9.5 group (0.0% 
vs. 6.4% vs. 19.6%; p = 0.012). However, the hospitalization due to angina rates in all groups was not 
significantly different (4.3% vs. 4.2% vs. 4.3%; p = 1.000). The multivariate analysis revealed that RSS >9.5 was 
the strong predictor for repeat revascularization during 1 year follow-up (Odds ratio [OR] = 9.605; 95% 
confidence interval [CI] = 1.207 - 76.458; p = 0.033). 
Conclusion: The greater RSS was associated with the higher 1-year POCE and repeat revascularization rate in CCS 
patients. The high RSS was also the strong predictor for 1-year repeat revascularization for CCS patients. 
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 Coronary artery disease (CAD) is a chronic disease due to 
atherosclerotic plaque generation in the epicardial coronary arteries.1,2 
Globally, CAD has been recognized as the number one cause of death.2,3 
Every year, at least 470,000 Indonesian people are estimated to die due 
to stroke or CAD.4 The dynamic nature of CAD manifests as the various 
clinical presentation. Acute coronary syndromes (ACS) and chronic 
coronary syndromes (CCS) are the clinical manifestations of CAD.1 The 
CCS is a new terminology that replaces “stable CAD.” It is a progressive 
atherosclerotic plaque accumulation process accompanied by function-
al changes in the epicardial coronary artery.1 Myocardial revasculariza-
tion through coronary artery bypass graft (CABG) or percutaneous 
coronary intervention (PCI) are the cornerstones of the CCS treatment 
strategy.1,5 Complete revascularization has to be achieved during 
conducting PCI or CABG. However, in a particular circumstance, 
complete revascularization cannot be achieved by PCI because of 
several reasons.6
 The severity and complexity of coronary artery lesions can be
assessed using the SYNTAX score.7,8 The residual SYNTAX score (RSS) 
can be used to measure the residual stenosis severity and complexity by 
calculating the SYNTAX score from post-PCI angiography.9 The ACUITY 
trial revealed that in non-ST elevation myocardial infarction (NSTEMI), 
the RSS >8 could independently predict 1-year ischemic events and 
mortality.10 A study from Altekin et al. demonstrated that in ST-eleva-
tion myocardial infarction (STEMI), the higher RSS was associated 
with the greater ischemic cardiac events.11 The prognostic role of RSS 
in CCS patients is still unknown. In this prospective study, we purposed 
to investigate the impact of RSS on the clinical outcomes following PCI 
in CCS patients.
2. Methods
2.1 Study design and participants
 We conducted a prospective cohort study in dr. Saiful Anwar 
General Hospital Malang, East Java, Indonesia in 2016. This cohort 
study conformed with the declaration of Helsinki principles and was 
recognized by the local research ethics board. Before collecting data,
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patients or their family members had signed the informed consent.
 In this study, we included: (1) all CCSs patient who under-
went PCI, (2) aged >40 years; (3) previous history of myocardial 
infarction (MI) or positive exercise stress test result; (4) treated with 
optimal medical treatment based on guideline; and (5) good adherence 
to the medication. The exclusion criteria were: (1) lost to follow-up; (2) 
incomplete data; (3) disability to conduct physical activities; (4) 
myocardial infarction within two weeks following PCI procedure; and 
(5) psychiatric disorders. All essential data regarding clinical, 
angiographic, and procedural characteristics data were collected from 
the direct interview and medical record. Our study flowchart was 
displayed in figure 1
2.2 Residual SYNTAX score assessment
 The RSS was determined from coronary angiogram reading 
by using the online calculator. Residual SYNTAX is estimated based on 
these following parameters: (1) the dominant vessel; (2) number of 
coronary lesions; (3) segment involved; (4) aorto-ostial lesion; (5) 
bifurcation; (6) trifurcation; (7) total occlusion; (8) lesion length; (9) 
tortuosity; (10) thrombus; (11); calcification and (12) diffuses 
disease.7,12 Two investigators conducted the RSS assessment. The 
suggestion from the third investigator resolved the discrepancy in the 
RSS assessment between the two investigators. Based on the residual 
SYNTAX score, patients were divided into three groups: RSS 0, RSS 0 
to 9.5, and RSS >9.5.
2.3 Clinical outcomes
The primary outcome in this study was patient-oriented composite 
endpoint (POCE). The definition of POCE was the composite of repeat 
revascularization, myocardial infarction, and all-cause mortality.13
vs. 21.3% vs. 63.0%; p <0.001) from the angiographic characteristics. 
The baseline SYNTAX score (8.00 [7.00 - 12.00] vs. 16.00 [10.00 - 
20.50] vs. 25.50 [19.13 - 32.13]; p <0.001) and residual CTO propor-
tion (0.0% vs. 12.8% vs. 43.5%; p <0.001) were greater in RSS >9.5 
group. However, SYNTAX score reduction was greater in RSS 0 to 9.5 
group (8.00 [7.00 - 12.00] vs. 11.00 [7.00 - 18.00] vs. 6.50 [2.00 - 
All-cause mortality, repeat revascularization, and hospitalization due to 
angina were the secondary outcomes of this study. The information 
regarding those clinical outcomes was obtained from the medical 
record or phone call.
2.4 Statistical analysis
 The IBM Statistical Package for Social Science (SPSS version 
25.0) was used in processing data. The number and percentage were 
used to show the categorical data. Mean and standard deviation (SD) 
were used to describe continuous data with normal distribution. On the 
other hand, median and interquartile range (IQR: the 25th percentile 
[0.25 quantile] and the 75th percentile [0.75 quantile]) were used to 
show continuous data with the abnormal distribution. We used the 
Shapiro-Wilk test and the Kolmogorov-Smirnov test to evaluate contin-
uous data normality. The analysis of variance (ANOVA) or Kruskal 
Wallis tests were used to compare continuous data with or without 
normal distribution, respectively. The Chi-squared test and Kolmogor-
ov-Smirnov test were used to compare categorical data. The p-value 
was less than 0.05 was considered statistically significant.
3. Results
3.1 Baseline characteristics
 At the beginning of the study, we registered and assessed 
RSS in 145 CCS patients. We excluded 29 patients because of loss to 
follow-up (n = 14) and incomplete data (n =15). A total of 116 
patients were included in the data analysis (RSS 0 [n = 23]; RSS 0 to 
9.5 [n = 47], and RSS >9.5 [n = 46]). Overall, the baseline character-
istics among the three groups were not significantly different. Patients 
in RSS >9.5 group revealed a greater proportion of three-vessel disease 
(8.7% vs. 59.6% vs. 76.1%; p <0.001), left main disease (0.0% vs. 
0.0% vs. 13%; p = 0.003), and chronic total occlusion (CTO) (17.4%
12.00]; p <0.001) (Table 1).
3.2 Clinical outcomes
 All patients for whom the loss of follow-up was not included 
in the data analysis. After 1-year follow-up period, patients in RSS >9.5 
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Figure 1. Study flowchart. CCS = chronic coronary syndromes; PCI = percutaneous coronary intervention.
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Table 1. Baseline characteristics
ACEi = angiotensin-converting enzyme inhibitor; ARB = angiotensin receptor blocker; BMS = bare metal stent; CAD = coronary artery disease; CTO = chronic total 
occlusion; DES = drug-eluting stent; LAD = left anterior descending; PCI = percutaneous coronary intervention; RCA = right coronary artery; RWMA = regional wall 
motion abnormality.
data in Indonesian population with no loss of follow-up. We evaluated 
the severity of incomplete revascularization using RSS and its effect on 
the clinical outcomes in CCS patients. Several essential findings were 
obtained from this prospective cohort study. First, the greater RSS was 
associated with the higher 1-year POCE and repeat revascularization 
rate in CCS patients. Second, in CCS patients, the high RSS (RSS >9.5) 
was the strong predictor for 1-year repeat revascularization. 
 Atherosclerosis formation is the key pathogenesis in CAD. It 
is slowly progressing for several decades. The atherosclerosis risk 
factors including, male sex, genetics, dyslipidemia, obesity, hyperten-
sion, diabetes mellitus, or sedentary lifestyle induce a low-grade 
inflammation. That low-grade inflammation has the critical role in the 
atherosclerosis process acceleration. In CCS, this slowly progressive 
group revealed the greater POCE (4.3% vs. 6.4% vs. 23.9%; p = 0.016) 
than others. The repeat revascularization rate also was greater in the 
RSS >9.5 group (0.0% vs. 6.4% vs. 19.6%; p = 0.012). However, the 
hospitalization due to angina rates in all groups was not significantly 
different (4.3% vs. 4.2% vs. 4.3%; p = 1.000). Only one patient in RSS 
>9.5 group passed away during the follow-up period. The summary of 
the outcomes is presented in Table 2. The multivariate analysis 
revealed that RSS >9.5 was the strong predictor for repeat revascular-
ization during 1 year follow-up (Odds ratio [OR] = 9.605; 95% 
confidence interval [CI] = 1.207 - 76.458; p = 0.033)
4. Discussion
 This prospective cohort study represented the real-world
Variables 
Residual SYNTAX Score 
P- value 0 (n = 23) 0 to 9.5 (n = 47) >9.5 (n = 46) 
  
Clinical characteristics  
Age. years 59.00 ± 8.26 59.68 ± 8.65 59.78 ± 8.08 0.930 
Male 16 (69.6) 37 (78.7) 40 (87.0) 0.221 
Body weight. kg 66.13 ± 9.06 68.72 ± 11.25 67.76 ± 9.73 0.611 
Diabetes mellitus 5 (21.7) 18 (38.3) 14 (30.4) 0.363 
Hypertension 18 (78.3) 31 (66.0) 24 (52.2) 0.091 
Dyslipidemia 13 (56.5) 23 (48.9) 25 (54.3) 0.798 
Active smoker 3 (13.0) 13 (27.7) 18 (39.1) 0.077 
Myocardial infarction 5 (21.7) 6 (12.8) 12 (26.1) 0.264 
PCI 5 (21.7) 19 (40.4) 18 (39.1) 0.270 
Family history of CAD 4 (17.4) 8 (17.0) 10 (21.7) 0.826 
Stroke 1 (4.3) 5 (10.6) 7 (15.2) 0.397 
Serum creatinine. mg/dl 1.02 (0.83 - 1.31) 1.03 (0.92 - 1.26) 1.05 (0.92 - 1.18) 0.938 
Creatinine clearance. ml/min 61.15 (43.77 - 91.08) 67.81 (46.18 - 87.70) 70.08 (60.94 - 85.67) 0.515 
RWMA 9 (39.1) 16 (34.0) 23 (50.0) 0.475 
Ejection fraction. % 52.75 ± 14.44 53.94 ± 13.37 47.51 ± 17.62 0.326 
Aspirin 23 (100.0) 47 (100.0) 45 (97.8) 0.856 
Clopidogrel 23 (100.0) 47 (100.0) 44 (95.7) 0.449 
β-blocker 15 (65.2) 29 (61.7) 29 (63.0) 0.960 
ACEi 6 (26.1) 13 (27.7) 22 (47.8) 0.074 
ARB 11 (47.8) 17 (36.2) 17 (37.0) 0.609 
Statin 22 (95.7) 46 (97.9) 45 (97.8) 0.838 
Calcium channel blocker 2 (8.7) 13 (27.7) 5 (10.9) 0.052 
Nitrate 18 (78.3) 40 (85.1) 40 (87.0) 0.635 
     
Angiographic characteristics 
Number of diseased vessels 
1 vessel disease 
2 vessels disease  














Left main disease 0 (0.0) 0 (0.0) 6 (13.0) 0.003 
CTO 4 (17.4) 10 (21.3) 29 (63.0) <0.001 
Baseline SYNTAX score 8.00 (7.00 - 12.00) 16.00 (10.00 - 20.50) 25.50 (19.13- 32.13) <0.001 
Reference vessel diameter 2.83 ± 0.39 2.87 ± 0.45 2.81 ± 0.53 0.805 
     
Procedural characteristics 
LAD alone revascularization 16 (69.6) 22 (46.8) 23 (50.0) 0.182 
RCA alone revascularization 3 (13.0) 7 (14.9) 9 (19.6) 0.740 
Ostial lesion revascularization 2 (8.7) 2 (4.3) 8 (17.4) 0.283 
In-stent restenosis treatment 1 (4.3) 1 (2.1) 0 (0.0) 0.906 
Number of implanted stents 1.30 ± 0.47 1.59 ± 0.95 1.37 ± 0.80 0.480 













Δ SYNTAX score 8.00 (7.00 - 12.00) 11.00 (7.00 - 18.00) 6.50 (2.00 - 12.00) 0.021 
 Residual CTO 0 (0.0) 6 (12.8) 20 (43.5) <0.001 
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be caused by several reasons: (1) small number of study participants; 
(2) not long enough follow-up period; and (3) the optimal use of 
antianginal drugs. 
 Some important lessons can be drawn from our current 
research. First, our research provided the data about the benefit of 
complete revascularization (RSS 0) in reducing 1-year POCE and 
repeat revascularization in CCS patients who underwent PCI. Second, 
incomplete revascularization with high RSS was the strong predictor 
for 1-year repeat revascularization. However, our current research had 
some limitations. First, this study was a single-center study. Second, 
our present study included small number of patients compared to the 
previous studies.10,11,13,24 Third, even though we conducted multivariate 
analysis to overcome significant confounders, we cannot manage the 
other confounders that may bring the significant impact on the study 
results. Fourth, we did not compare the prognostic value of RSS with 
the novel SYNTAX-II score, which includes clinical and angiographic 
parameters.25  Because of those several drawbacks, a randomized 
controlled trial (RCT) with better design, larger study population, and 
longer follow-up is required. 
5. Conclusion
 Our study demonstrated that the greater RSS was associated 
with the higher 1-year POCE and repeat revascularization rate in CCS 
patients. The high RSS was the strong predictor for 1-year repeat 
revascularization for CCS patients. The RSS can be used to guide the 
level of revascularization determination and the next revascularization 
strategy. 
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atherosclerotic process results in coronary artery inner layer thicken-
ing. The final result of this process was coronary artery lumen narrow-
ing with diverse severity.14  The coronary artery stenosis severity can be 
assessed non-invasively using computed tomography angiography 
(CTA) or invasively using coronary angiography (CAG). However, until 
now, the CAG is still the gold standard tool in evaluating coronary 
artery stenosis severity.15 In determining the vessel wall and atheroscle-
rotic plaque morphology, other imaging modalities including, optical 
coherence tomography (OCT) and intravascular ultrasound (IVUS), are 
required.16,17 In certain conditions, myocardial ischemia occurs because 
the stenotic blood vessels fails to compensate the raised myocardial 
oxygen demand.18,19 The compensatory vasodilation is not helpful if the 
coronary artery lumen stenosis is greater than 80% of lumen diameter. 
Endothelial disfunction, microvessel disease, or vascular spasm may 
increase the ischemia.19 Complete revascularization with PCI is 
recognized to be beneficial because it can significantly improve myocar-
dial infarction and cardiovascular death.20 However, around 59% of 
patients have incomplete revascularization following PCI procedure.21  
 SYNTAX score has been developed to determine coronary 
artery lesions’ complexity or severity. The higher SYNTAX score 
represents a more complex and more severe coronary artery lesion. It is 
also correlated with bad prognosis in CAD patients receiving PCI.7,8 For 
CAD patients with complex lesions such as three-vessel disease or 
multivessel CAD, the high SYNTAX was a strong predictor for major 
adverse cardiovascular events (MACE) or mortality.22,23 The residual 
SYNTAX score can be calculated from post-PCI angiography to assess 
the complexity and severity of the residual stenotic lesion.9 It is import-
ant to stratify the patients and prepare the next revascularization 
strategy.
 Our results supported the findings of the prior studies. In the 
EXCELLENT registry, the higher RSS (RSS >7) was associated with 
increased 1-year POCE and repeat revascularization. Moreover, in that 
study, the high RSS was recognized as the significant predictor for 
1-year POCE.13 A study from Yan et al. revealed that incomplete 
revascularization (RSS >8) increased the risk of MACE, MI, cardiac 
mortality, all-cause mortality, repeat revascularization, and stroke.24 
Both studies included all ACS and CCS patients. However, our current 
study only included CCS patients. In the ACS setting, two previous 
studies revealed that RSS had an excellent performance in predicting 
the poor prognosis. The ACUITY trial revealed that in NSTEMI, the RSS 
>8 could independently predict 1-year ischemic events and mortality.10 
Altekin et al. demonstrated that the higher RSS (RSS >7) was associat-
ed with the greater ischemic cardiac events in STEMI patients.11 This 
study demonstrated that higher RSS was not associated with higher 
rehospitalization because of angina. This finding was not reported in 
the prior studies.10,11,13,24 In theory, complete revascularization (RSS 0) 
can provide better clinical outcomes regarding angina or rehospitaliza-
tion because of angina. However, our finding failed to prove it. It could
Table 2. Outcomes
POCE = patient-oriented composite end point.
Outcomes Residual SYNTAX Score P- value 
0 (n = 23) 0 to 9.5 (n = 47) >9.5 (n = 46) 
 
Primary outcome 
POCE 1 (4.3) 3 (6.4) 11 (23.9) 0.016 
     
Secondary outcomes 


















Hospitalization due to angina 1 (4.3) 2 (4.2) 2 (4.3) 1.000 
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